Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Update

Idorsia Ltd (OTCMKTS:IDRSFGet Free Report) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,760,300 shares, a decline of 28.3% from the February 28th total of 5,248,000 shares. Based on an average daily volume of 300 shares, the short-interest ratio is currently 12,534.3 days.

Idorsia Stock Performance

IDRSF stock remained flat at $1.05 on Friday. Idorsia has a 52 week low of $0.70 and a 52 week high of $2.88. The business’s 50 day moving average price is $1.00 and its 200 day moving average price is $1.34.

About Idorsia

(Get Free Report)

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.

Read More

Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.